Complement Pharma Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.41M

Complement Pharma General Information

Description

Developer of monoclonal antibody intended to treat neurodegenerative and immune-mediated disorders. The company's monoclonal antibody targets the complement pathway in order to treat immune-mediated disorders and accelerate nerve regeneration in neurological disorders and drug therapies for neurological disorders, thereby enabling patients to get an early-stage drug that treats and meets the unmet medical need.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Meibergdreef 9, K2 - 217
  • 1105 Amsterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Meibergdreef 9, K2 - 217
  • 1105 Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Complement Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 11-Jun-2018 $1.41M Completed Generating Revenue
3. Early Stage VC 01-Jan-2014 Completed Generating Revenue
2. Debt - General 12-Oct-2011 $5M $5.9M Completed Generating Revenue
1. Seed Round 03-Dec-2010 $900K $900K Completed Generating Revenue
To view Complement Pharma’s complete valuation and funding history, request access »

Complement Pharma Patents

Complement Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016118007-A1 Means and methods for counteracting complement-mediated hemolytic anemia Inactive 21-Jan-2015
AU-2015365583-A1 Antibodies that bind human c6 and uses thereof Active 19-Dec-2014
AU-2015365583-B2 Antibodies that bind human c6 and uses thereof Active 19-Dec-2014
AU-2021240139-A1 Antibodies that bind human c6 and uses thereof Active 19-Dec-2014
AU-2021240139-B2 Antibodies that bind human c6 and uses thereof Active 19-Dec-2014 A61K39/395
To view Complement Pharma’s complete patent history, request access »

Complement Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Complement Pharma Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amsterdam UMC Ventures Holding Venture Capital Minority
Life Sciences Fund Amsterdam Venture Capital Minority
Stichting ALS Nederland Corporation Minority
UvA Ventures Holding Venture Capital Minority
Ventac Partners Venture Capital Minority
To view Complement Pharma’s complete investors history, request access »

Complement Pharma FAQs

  • When was Complement Pharma founded?

    Complement Pharma was founded in 2009.

  • Where is Complement Pharma headquartered?

    Complement Pharma is headquartered in Amsterdam, Netherlands.

  • What is the size of Complement Pharma?

    Complement Pharma has 1 total employees.

  • What industry is Complement Pharma in?

    Complement Pharma’s primary industry is Drug Discovery.

  • Is Complement Pharma a private or public company?

    Complement Pharma is a Private company.

  • What is the current valuation of Complement Pharma?

    The current valuation of Complement Pharma is .

  • What is Complement Pharma’s current revenue?

    The current revenue for Complement Pharma is .

  • How much funding has Complement Pharma raised over time?

    Complement Pharma has raised $6.72M.

  • Who are Complement Pharma’s investors?

    Amsterdam UMC Ventures Holding, Life Sciences Fund Amsterdam, Stichting ALS Nederland, UvA Ventures Holding, and Ventac Partners have invested in Complement Pharma.

  • When was Complement Pharma acquired?

    Complement Pharma was acquired on 11-Jun-2018.

  • Who acquired Complement Pharma?

    Complement Pharma was acquired by Alexion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process